Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-19-010493
Filing Date
2019-09-19
Accepted
2019-09-19 16:29:18
Documents
1
Period of Report
2019-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4059
  Complete submission text file 0001179110-19-010493.txt   5495
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B14202 CAMBRIDGE MA 02139
Business Address
Komjathy Andrew (Reporting) CIK: 0001788465 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 191102019